Inogen (INGN) Other Non Operating Income (2013 - 2026)
Inogen's (INGN) quarterly Other Non Operating Income came in at -$42000.0 in Q1 2026, up 95.14% year-on-year from -$21522.5 in Q1 2025, and down 103.12% on a QoQ basis from $1.3 million in Q4 2025.
Inogen (INGN) Other Non Operating Income (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Other Non Operating Income data on file, last reported at -$42000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 95.14% year-over-year to -$42000.0 in Q1 2026; TTM through Mar 2026 was $2.6 million, a 1752.53% increase from a year earlier, with the FY2025 full-year figure at $701000.0, down 17.53% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$42000.0, down from $1.3 million in the prior quarter.
- Over the last five years, Other Non Operating Income for INGN reached as high as $1.3 million in Q4 2025 and fell as low as -$865000.0 in Q1 2025.
- Historically, Other Non Operating Income has averaged $161823.5 across 5 years, with a median of $143000.0 in 2024.
- Across the five-year window, Other Non Operating Income jumped 1437.04% in 2023 and sank 704.9% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $27000.0 in 2022, then soared by 1437.04% to $415000.0 in 2023, then slumped by 127.47% to -$114000.0 in 2024, then surged by 1280.7% to $1.3 million in 2025, then plunged by 103.12% to -$42000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$42000.0 in Q1 2026, $1.3 million in Q4 2025, and $606000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 606,000.00 |
| Jun 30, 2025 | 701,000.00 |
| Mar 31, 2025 | -865,000.00 |
| Dec 31, 2024 | -114,000.00 |
| Sep 30, 2024 | 687,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 415,000.00 |
| Sep 30, 2023 | -398,000.00 |
| Jun 30, 2023 | 337,000.00 |
| Mar 31, 2023 | 237,000.00 |
| Dec 31, 2022 | 27,000.00 |
| Sep 30, 2022 | 209,000.00 |
| Jun 30, 2022 | -598,000.00 |
| Mar 31, 2022 | -74,000.00 |
| Dec 31, 2021 | -2.47 Mn |
| Sep 30, 2021 | 600,000.00 |
| Jun 30, 2021 | 304,000.00 |